Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, disposed of 2,141 shares of common stock on March 6, 2025, to cover tax liabilities related to vesting restricted stock units.
Summary
- On March 6, 2025, William J. Peters, the CFO, EVP, and Treasurer of Amphastar Pharmaceuticals, disposed of 2,141 shares of common stock.
- The transaction was executed to satisfy the reporting person's tax liability associated with the vesting of restricted stock units (RSUs).
- The shares were sold at a price of $28.32 per share.
- Following the transaction, Peters directly owns 93,483 shares of Amphastar Pharmaceuticals' common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock disposal transaction. |
| 03/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.